1. Generics Bulletin

Eden Hands Keys To CDMO Unit Over To Bora Pharmaceuticals

Taiwanese Biologics Developer Will Maintain Relationship With Spun-Out Unit

 
• By Chloe Kent

Eden Biologics has sold its CDMO business to Bora Pharmaceuticals’ recently-established biologics CDMO platform Bora Biologics. The firm appears keen to maintain a working relationship with its former unit following the sale.

Car salesman passing key to customer
Bora Biologics will take over Eden's CDMO unit • Source: Shutterstock

Eden Biologics, Inc. CEO and director Steven Lee has announced that the company has completed a deal for its contract development and manufacturing operations unit to be acquired by Bora Pharmaceuticals. The two companies entered into a definitive agreement on 10 May.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Strategy

More from Business